Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: An observational prospective cohort study

Nutrition Research

Volumn 34, Issue 2, 2014, Pages 149-154

  Sundaram, Maria E ^a   Meydani, Simin Nikbin ^b   Vandermause, Mary ^a   Shay, David K ^c   Coleman, Laura A ^a,d  

^a MARSHFIELD CLINIC   (United States)

^b TUFTS UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Immune response; Influenza; Observational prospective cohort study; Vaccine; Vitamin A; Vitamin E; Zinc

Indexed keywords

ALPHA TOCOPHEROL; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; RETINOL; TRACE ELEMENT; TRIPLE VACCINE; ZINC;

AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; AUTUMN; BLOOD DONOR; BODY MASS; COHORT ANALYSIS; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SEROLOGY; SEX DIFFERENCE; SPRING; UNITED STATES; VERY ELDERLY; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

BMI; BODY MASS INDEX; CI; CONFIDENCE INTERVAL; GEOMETRIC MEAN TITER; GMT; HAI; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; INFLUENZA; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY III; NHANES III; OBSERVATIONAL PROSPECTIVE COHORT STUDY; ODDS RATIO; OR; SD; STANDARD DEVIATION; VACCINE; VITAMIN A; VITAMIN E; ZINC;

AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; ANTIBODIES, VIRAL; DEFICIENCY DISEASES; FEMALE; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; NUTRITIONAL STATUS; PREVALENCE; PROSPECTIVE STUDIES; SEASONS; VACCINATION; VITAMIN A; WISCONSIN; ZINC;

EID: 84892870013     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.12.004     Document Type: Article

References (40)

1. Kurowska K., Whaley P. Demographic change and an ageing population: the policy context (a report for the Transnational European Social Fund Project 'Changing People-Rising to the challenge of demographic change in the North East of England and beyond') 2011, Newcastle University Institute for Ageing and Health.
2. Aspinall R., Del Giudice G., Effros R.B., Grubeck-Loebenstein B., Sambhara S. Challenges for vaccination in the elderly. Immun Ageing 2007, 4:9.
3. Aw D., Silva A.B., Palmer D.B. Immunosenescence: emerging challenges for an ageing population. Immunology 2007 Apr, 120(4):435-446.
4. Simonsen L., Fukuda K., Schonberger L.B., Cox N.J. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000, 181:831-837.
5. Influenza vaccines: position paper 2005, World Health Organization, Geneva.
6. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., Strikas R.A. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006, 55(RR10):1-42.
7. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
8. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006 Apr, 35(2):337-344.
9. Meydani S.N., Han S.N., Wu D. Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev 2005, 205:269-284.
10. Drewnowski A., Warren-Mears V.A. Does aging change nutrition requirementsα. J Nutr Health Aging 2001, 5(2):70-74.
11. van Staveren W.A., de Groot L. Evidence-based dietary guidance and the role of dairy products for appropriate nutrition in the elderly. J Am Coll Nutr 2011, 30(5):429S-437S.
12. Armijos R.X., Weigel M.M., Chacon R., Flores L., Campos A. Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Publica Mex 2009, 52(3):185-189.
13. Meydani S.N., Meydani M., Blumberg J.B., et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. J Am Med Assoc 1997, 277(17):1380-1386.
14. Allsup S.J., Shenkin A., Gosney M.A., et al. Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccineα A randomized, controlled trial. J Am Geriatr Soc 2004, 52:20-24.
15. Provinciali M., Montenovo A., Di Stefano G., et al. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing 1998 Nov, 27(6):715-722.
16. Talbot H.K., Coleman L.A., Crimin K., et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine 2012, 30:3937-3943.
17. Bieri J.G., Tolliver T.J., Catignani G.L. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 1979, 32:2143-2149.
18. Smith J.C., Butrimovitz G.P., Purdy W.C. Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem 1979, 25(8):1487-1491.
19. Bridges C.B., Katz J.M., Levandowski R.A., Cox N.J. Inactivated influenza vaccines. Vaccines 2008, 271-272. Elsevier, United States. 5th ed. S. Plotkin, W. Orenstein, P. Offit (Eds.).
20. Hamer D.H., Sempertegui F., Estrella B., et al. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J Nutr 2009 Jan, 139(1):113-119.
21. Halsted J.A., Smith J.C., Irwin M.I. A conspectus of research on zinc requirements of man. J Nutr 1974, 104(3):345-378.
22. Goodwin J.S., Garry P.J. Relationship between megadose vitamin supplementation and immunological function in a healthy elderly population. Clin Exp Immunol 1983, 51:647-653.
23. Gardner E.M., Bernstein E.D., Popoff K.A., Abrutyn E., Gross P., Murasko D.M. Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc. Mech Ageing Dev 2000, 117(1-3):29-45.
24. Hara M., Tanaka K., Hirota Y. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine 2004, 23:1457-1463.
25. Hooper P.L., Hooper E.M., Hunt W.C., Garry P.J., Goodwin J.S. Vitamins, lipids and lipoproteins in a healthy elderly population. Int J Vitam Nutr Res 1983, 412-419.
26. Garcia O.P., Long K.Z., Rosado J.L. Impact of micronutrient deficiencies on obesity. Nutr Rev 2009 Oct, 67(10):559-572.
27. Garenne M., Becher H., Ye Y., Kouyate B., Müller O. Sex-specific responses to zinc supplementation in Nouna, Burkina Faso. J Pediatr Gastroenterol Nutr 2007, 44:619-628.
28. Fang Y., Banner D., Kelvin A.A., et al. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. J Virol 2011, 86(4):2229-2238.
29. Hannoun C., Megas F., Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004 Jul, 103(1-2):133-138.
30. Xie H., Jing X., Li X., et al. Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS ONE 2011, 6(1):e16650.
31. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies-United States 2012, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), Atlanta, GA.
32. Eichelberger M., Golding H., Hess M., et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12, 26(34):4299-4303.
33. Beyer W.E., Palache A.M., Luchters G., Nauta J., Osterhaus A.D. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccinationα. Virus Res 2004 Jul, 103(1-2):125-132.
34. Administration FaD Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines [cited 2013 February 18]; Available from:. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074794.htm.
35. Marko M.G., Ahmed T., Bunnell S.C., et al. Age-associated decline in effective immune synapse formation of CD4+ T cells is reversed by vitamin E supplementation. J Immunol 2007, 178:1443-1449.
36. Han S.N., Adolfsson O., Lee C.-K., Prolla T.A., Ordovas J., Meydani S.N. Age and vitamin E-induced changes in gene expression profiles of T cells. J Immunol 2006, 177:6052-6061.
37. Marko M.G., Pang H.J., Ren Z., et al. Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice. J Nutr 2009 Jun, 139(6):1192-1197.
38. Beck M.A. Selenium and vitamin E status: impact on viral pathogenicity. J Nutr 2007, 137:1338-1340.
39. Barnett J.B., Hamer D.H., Meydani S.N. Low zinc status: a new risk factor for pneumonia in the elderlyα. Nutr Rev 2010 Jan, 68(1):30-37.
40. Ford L., Farr J., Morris P., Berg J. The value of measuring serum cholesterol-adjusted vitamin E in routine practice. Ann Clin Biochem 2006, 43(2):130-134.